19 June 2019 | News
This strategic partnership will enable cell and gene therapy developers to benefit from an integrated suite of industry-leading services and technology platforms
Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and TrakCel, a software developer for cell and gene therapy supply chain tracking and orchestration systems have announced a collaboration that will provide integrated solutions for companies developing cell and gene therapies.
This strategic partnership will enable cell and gene therapy developers to benefit from an integrated suite of industry-leading services and technology platforms. This combination of services and platforms has been designed to improve operations at every step of the cell and gene therapy supply chain. These steps range from clinical delivery to commercial-scale operations and coordination of these activities through a single software platform.
Be The Match BioTherapies and TrakCel will identify the unique challenges faced by cell and gene therapy developers and integrate services and platforms that provide direct solutions. Be The Match BioTherapies will contribute solutions for cell sourcing, cell therapy supply chain, clinical study design and execution, cellular therapy outcomes registry, and IT systems.
TrakCel will provide its chain of custody/chain of identity (COC/COI), scheduling and logistics management software platform. The integration will increase efficiencies and eliminate redundancies while supporting all aspects of the supply chain in accordance with regulatory and protocol requirements. Both companies are already working together to deliver the integrated offering in support of a client’s CAR-T development program.